A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

NCT00631488 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: MK-0893
DRUG: Sitagliptin
DRUG: Metformin
DRUG: Placebo for MK-0893
DRUG: Placebo for Sitagliptin
DRUG: Placebo for Metformin

Sponsor

Merck Sharp & Dohme LLC